These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26653715)

  • 1. A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles.
    Lin Z; Monteiro-Riviere NA; Kannan R; Riviere JE
    Nanomedicine (Lond); 2016 Jan; 11(2):107-19. PubMed ID: 26653715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically based pharmacokinetic modeling for nanoparticle toxicity study.
    Li M; Reineke J
    Methods Mol Biol; 2012; 926():369-82. PubMed ID: 22975976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice.
    Lin Z; Monteiro-Riviere NA; Riviere JE
    Nanotoxicology; 2016; 10(2):162-72. PubMed ID: 25961857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling.
    Cheng YH; Riviere JE; Monteiro-Riviere NA; Lin Z
    Nanotoxicology; 2018 Jun; 12(5):453-469. PubMed ID: 29658401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
    Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
    Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of clearance, retention, and translocation of inhaled gold nanoparticles in rats.
    Krikas A; Neofytou P; Gakis GP; Xiarchos I; Charitidis C; Tran L
    Inhal Toxicol; 2022; 34(13-14):361-379. PubMed ID: 36053230
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo testing of gold nanoparticles using the Caenorhabditis elegans model organism.
    Gonzalez-Moragas L; Berto P; Vilches C; Quidant R; Kolovou A; Santarella-Mellwig R; Schwab Y; Stürzenbaum S; Roig A; Laromaine A
    Acta Biomater; 2017 Apr; 53():598-609. PubMed ID: 28161575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments.
    Bachler G; Losert S; Umehara Y; von Goetz N; Rodriguez-Lorenzo L; Petri-Fink A; Rothen-Rutishauser B; Hungerbuehler K
    Part Fibre Toxicol; 2015 Jun; 12():18. PubMed ID: 26116549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats.
    Chou WC; Cheng YH; Riviere JE; Monteiro-Riviere NA; Kreyling WG; Lin Z
    Part Fibre Toxicol; 2022 Jul; 19(1):47. PubMed ID: 35804418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic effects and biodistribution of ultrasmall gold nanoparticles.
    Schmid G; Kreyling WG; Simon U
    Arch Toxicol; 2017 Sep; 91(9):3011-3037. PubMed ID: 28702691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic in vitro toxicological screening of gold nanoparticles designed for nanomedicine applications.
    Naha PC; Chhour P; Cormode DP
    Toxicol In Vitro; 2015 Oct; 29(7):1445-53. PubMed ID: 26031843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Assessment and Translation of Physiologically Based Pharmacokinetic Models From acslX to Berkeley Madonna, MATLAB, and R Language: Oxytetracycline and Gold Nanoparticles As Case Examples.
    Lin Z; Jaberi-Douraki M; He C; Jin S; Yang RSH; Fisher JW; Riviere JE
    Toxicol Sci; 2017 Jul; 158(1):23-35. PubMed ID: 28402537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
    Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
    Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessment.
    Lipscomb JC; Haddad S; Poet T; Krishnan K
    Adv Exp Med Biol; 2012; 745():76-95. PubMed ID: 22437814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative in vitro to in vivo extrapolation of tissues toxicity.
    Hamon J; Renner M; Jamei M; Lukas A; Kopp-Schneider A; Bois FY
    Toxicol In Vitro; 2015 Dec; 30(1 Pt A):203-16. PubMed ID: 25678044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles.
    Deng L; Liu H; Ma Y; Miao Y; Fu X; Deng Q
    Toxicol Appl Pharmacol; 2019 Dec; 384():114765. PubMed ID: 31669777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species extrapolation of life-stage physiologically-based pharmacokinetic (PBPK) models to investigate the developmental toxicology of ethanol using in vitro to in vivo (IVIVE) methods.
    Martin SA; McLanahan ED; Bushnell PJ; Hunter ES; El-Masri H
    Toxicol Sci; 2015 Feb; 143(2):512-35. PubMed ID: 25410581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation.
    Aborig M; Malik PRV; Nambiar S; Chelle P; Darko J; Mutsaers A; Edginton AN; Fleck A; Osei E; Wettig S
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 31013763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.